GLP-1 Receptor Agonists
Sponsors
RenJi Hospital, Advanced Reconstructive Surgery Alliance, Nemours Children's Clinic, Jinling Hospital, China, The First Affiliated Hospital with Nanjing Medical University
Conditions
Alzheimer DiseaseCancerCushing SyndromeDiabetesDiabetes Mellitus Type 2Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)Endocrine DiseasesIntestinal Failure
Early Phase 1
Phase 4
Unknown Phase
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
CompletedNCT02446834
Start: 2015-04-30End: 2018-04-30Updated: 2022-10-17
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
RecruitingNCT07169136
Start: 2025-09-11End: 2026-12-31Target: 20Updated: 2025-09-16
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
CompletedNCT07297238
Start: 2026-01-24End: 2026-06-30Updated: 2026-07-14
Antidiabetic Medications and Risk of Cancer
CompletedNCT07628556
Start: 2025-03-15End: 2025-12-30Updated: 2026-06-05
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
CompletedNCT07677865
Start: 2007-01-01End: 2026-06-24Updated: 2026-07-01
Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
RecruitingNCT07703683
Start: 2026-02-19End: 2056-12-31Target: 100Updated: 2026-07-14